Sodium butyrate induces a more differentiated and less tumorigenic phenotype of HT-29 human colon carcinoma cells in vitro. We have cloned a cDNA library of sequences expressed in HT-29 cells and have developed a computerized scanning and image processing system to quantitate the relative level of expression of each of 4000 members of this library in tissue biopsies or cells in culture. We will also produce two new more extensive cDNA libraries from cell lines which stably differentiated during treatment of HT-29 cells with butyrate. These cell lines, 16E and 19A, each exhibit properties of different lineages of colon cell differentiation (mucin secretion and vectorial transport), and these properties continue to be expressed in the absence of inducer. These libraries will be produced in the bacterial expression vector Lambdagt11. Utilizing all three libraries and the computer-linked methodology we have developed, we will identify sequences which are altered in expression during treatment with sodium butyrate, the time course of such alterations and association with acquisition of various traits characteristic of a more differentiated phenotype, the time necessary for commitment to such changes during butyrate treatment, and the stability and reversal of such changes after withdrawal of butyrate. In a continuation and extension of work we have done on expression of proto-onc sequences in the stably differentiated cell lines, we will investigate the expression of proto-onc sequences of the myc and ras gene family in these experiments. We will also determine the time course of change in gene expression in two other human colon carcinoma cell lines, SW480 and SW1116, during butyrate treatment in order to determine if similar changes are consistently observed in these other lines. Finally, a monoclonal antibody which recognizes the peptide of colon mucin will be used to isolate this mRNA from one of the Lambdagt11 libraries, and subsequently study the effects of sodium butyrate on expression of this gene in the experiments outlined.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA040558-02
Application #
3180684
Study Section
Experimental Therapeutics Subcommittee 2 (ET)
Project Start
1987-01-01
Project End
1989-12-31
Budget Start
1988-01-01
Budget End
1988-12-31
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Montefiore Medical Center (Bronx, NY)
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10467
Augenlicht, L H; Heerdt, B G (1992) Modulation of gene expression as a biomarker in colon. J Cell Biochem Suppl 16G:151-7
Heerdt, B G; Augenlicht, L H (1991) Effects of fatty acids on expression of genes encoding subunits of cytochrome c oxidase and cytochrome c oxidase activity in HT29 human colonic adenocarcinoma cells. J Biol Chem 266:19120-6
Augenlicht, L H; Taylor, J; Anderson, L et al. (1991) Patterns of gene expression that characterize the colonic mucosa in patients at genetic risk for colonic cancer. Proc Natl Acad Sci U S A 88:3286-9
Heerdt, B G; Molinas, S; Deitch, D et al. (1991) Aggressive subtypes of human colorectal tumors frequently exhibit amplification of the c-myc gene. Oncogene 6:125-9
Heerdt, B G; Augenlicht, L H (1990) Absence of detectable deletions in the mitochondrial genome of human colon tumors. Cancer Commun 2:109-11
Heerdt, B G; Augenlicht, L H (1990) Changes in the number of mitochondrial genomes during human development. Exp Cell Res 186:54-9
Heerdt, B G; Halsey, H K; Lipkin, M et al. (1990) Expression of mitochondrial cytochrome c oxidase in human colonic cell differentiation, transformation, and risk for colonic cancer. Cancer Res 50:1596-600
Augenlicht, L H; Wahrman, M Z; Halsey, H et al. (1987) Expression of cloned sequences in biopsies of human colonic tissue and in colonic carcinoma cells induced to differentiate in vitro. Cancer Res 47:6017-21
Augenlicht, L H; Augeron, C; Yander, G et al. (1987) Overexpression of ras in mucus-secreting human colon carcinoma cells of low tumorigenicity. Cancer Res 47:3763-5